Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Griesinger

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Deutsche Medizinische Wochenschrift (1946)|December 6, 2017
[Current Aspects of Diagnosis and Treatment of Lung Cancer]Frank Griesinger
Deutsche Medizinische Wochenschrift (1946)|April 14, 2021
[When to test in biomarker-stratified therapy of non-small cell lung cancer - Biomarker-stratified therapy of Non-small cell lung cancer: when and what to test?]Frank Griesinger, Michael Thomas
Current Opinion in Oncology|November 20, 2018
Epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer: what is the preferred first-line therapy?Julia Roeper, Frank Griesinger
Pneumologie (Stuttgart, Germany)|September 15, 2021
[When to Test in Biomarker-stratified Therapy of Non-small Cell Lung Cancer - Biomarker-stratified Therapy of Non-small Cell Lung Cancer: When and What to Test?]Frank Griesinger, Michael Thomas
Dermatology (Basel, Switzerland)|October 26, 2012
Two cases of psoriasis responding to erlotinib: time to revisiting inhibition of epidermal growth factor receptor in psoriasis therapy?Tobias R Overbeck, Frank Griesinger
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2007
Interpreting clinical trials in lung cancer: impact of methodology and endpointsRichard J Gralla, Frank Griesinger
Translational Lung Cancer Research|October 24, 2025
Refining maintenance strategies for metastatic nonsquamous non-small cell lung cancer: insights from the KEYLYNK-006 studyMarcel Kemper, Frank Griesinger, Annalen Bleckmann
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2017
Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid BiopsySotirios Lakis, Lukas C Heukamp, Frank Griesinger
Onkologie|September 16, 2006
[Pillnitz interdisciplinary discussion--summary]Ulrich Gatzemeier, Frank Griesinger, Rudolf M Huber
Onkologie|June 17, 2011
[Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]Frank Griesinger, Rudolf M Huber, Michael Thomas
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Deutsche Medizinische Wochenschrift (1946)|December 6, 2017
[Current Aspects of Diagnosis and Treatment of Lung Cancer]Frank Griesinger
Deutsche Medizinische Wochenschrift (1946)|April 14, 2021
[When to test in biomarker-stratified therapy of non-small cell lung cancer - Biomarker-stratified therapy of Non-small cell lung cancer: when and what to test?]Frank Griesinger, Michael Thomas
Current Opinion in Oncology|November 20, 2018
Epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer: what is the preferred first-line therapy?Julia Roeper, Frank Griesinger
Pneumologie (Stuttgart, Germany)|September 15, 2021
[When to Test in Biomarker-stratified Therapy of Non-small Cell Lung Cancer - Biomarker-stratified Therapy of Non-small Cell Lung Cancer: When and What to Test?]Frank Griesinger, Michael Thomas
Dermatology (Basel, Switzerland)|October 26, 2012
Two cases of psoriasis responding to erlotinib: time to revisiting inhibition of epidermal growth factor receptor in psoriasis therapy?Tobias R Overbeck, Frank Griesinger
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2007
Interpreting clinical trials in lung cancer: impact of methodology and endpointsRichard J Gralla, Frank Griesinger
Translational Lung Cancer Research|October 24, 2025
Refining maintenance strategies for metastatic nonsquamous non-small cell lung cancer: insights from the KEYLYNK-006 studyMarcel Kemper, Frank Griesinger, Annalen Bleckmann
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2017
Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid BiopsySotirios Lakis, Lukas C Heukamp, Frank Griesinger
Onkologie|September 16, 2006
[Pillnitz interdisciplinary discussion--summary]Ulrich Gatzemeier, Frank Griesinger, Rudolf M Huber
Onkologie|June 17, 2011
[Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]Frank Griesinger, Rudolf M Huber, Michael Thomas
Pageof 16